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Abstract
Background: Altered sialylation has been observed during oncogenic transformation. Sialylated oligosaccharides of
glycoproteins and glycolipids have been implicated in tumor progression and metastases. In the cervical cancer
high levels of sialic acid have been reported in the patients serum, and an increased of total sialic acid
concentration has been reported for the cervical neoplasia and cervical cancer. This study investigates the changes
in expression and distribution of a2,3-linked sialic acid and a2,6- linked sialic acid in low and high squamous
intraepithelial lesions and in normal tissue.
Methods: Lectin histochemistry was used to examine the expression and distribution of sialic acid in different
grades of cervical neoplasia. We applied Maackia amurensis lectin, which interacts with a2,3-linked sialic acid and
Sambucus nigra lectin specific for a2,6-linked sialic acid.
Results: The histochemical analysis showed that a2,3-linked sialic acid and a2,6- linked sialic acid increased in
intensity and distribution in concordance with the grade of squamous intraepithelial lesion (SIL). These results are
in concordance with a previous study that reports increased RNAm levels of three sialyltransferases.
Conclusions: These results show that the change in sialylation occurs before cancer development and may play
an important role in cellular transformation. These findings provide the basis for more detailed studies of the
possible role of cell surface glycoconjugates bearing sialic acid in the cellular cervix transformation.
Background
It is well known that tumorigenesis and metastasis are
frequently associated with altered structure and expres-
sion of oligosaccharides on cell surface glycoproteins
and glycolipids [1-6]. Sialylated glycoconjugates expres-
sion has been shown to change during development, dif-
ferentiation, and disease and oncogenic transformation.
A general increase in sialylation of cell surface glycocon-
jugates of carcinoma cells has been detected [7]. These
changes in sialylation are related to invasion and metas-
tasis [8-11].
Different studies in serum from patients with cervical
cancer showed that sialic acid is elevated even in the
early stages of carcinoma, and levels of these glycans
decreased to near normal levels after radiotherapy
[12,13]. Total sialic acid concentration of cervical tissue
has been analyzed. Results showed a slight elevation in
benign inflammatory lesions, moderate elevation in
severe dysplasia and preinvasive carcinoma and high ele-
vation in invasive cervical carcinoma [14]. Sialic acids
are widely distributed in nature as terminal sugars of
oligosaccharides attached to proteins or lipids. Sialic
acids are linked to galactose via a2,3 or a2,6-linkage or
linked via a2,6-linkage to galactosamine or N-acetylga-
lactosamine. Sialic acids may be linked to the C8 posi-
tion of another sialic acid residue [15]. The biosynthesis
of sialylated oligosaccharide sequences is catalyzed by a
family of enzymes named sialyltransferases [15]. A cor-
relation between sialic acid and sialyltransferase expres-
sion has been detected [16]. Altered expression of
sialyltransferase in different cancers is well documented
[17-20]. Increased expression of ST3Gal III and ST6Gal
I was correlated with poor prognosis and lymph node
metastasis in cervical cancer [21,22] In a previous study,
our group investigated the sialyltransferase expression in
cervical premalignant lesions and normal tissue.
Increased expression of ST3Gal III, ST3Gal IV and
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pithelial lesion (SIL) [23].
In the present study we have performed lectin histo-
chemistry in order to determine the level of expression
and the distribution of a2,3 and a2,6 sialic acid in nor-
mal tissue and in low- and high-grade cervical intrae-
pithelial lesions in order to determine the changes in
sialylation at early stages of transformation in cervical
neoplasia.
Materials and methods
Reagents
Sambucus nigra (SNA specific for NeuAca2,6Gal-Gal-
NAc); Maackia amurensis (MAA, specific for NeuA-
ca2,3Gal); and agglutinins biotinylated were purchased
from Vector (Burlingame, CA, USA) and used at a con-
centration of 5 μg/ml. Signal amplification was realized
with the TSA biotin system kit from NEN Life Science
(Boston, MA, USA).
Tissues
A retrospective study was carried out using material
from the tissue collection at the Clinics of Dysplasia,
Hospital General Regional No. 36 and Hospital General
de Zona No. 5, Metepec, Mexican Institute of Social
Security. Samples of normal cervix were obtained from
uterus of patients who had undergone total hysterect-
omy due to uterine myoma. The biopsies were fixed in
3% phosphate-buffered formaldehyde and embedded in
paraffin according to a standard protocol [24]. All sam-
ples were obtained according to the guidelines of the
Human Ethics Committee of our Institution. This study
involved 23 specimens classified by a pathologist accord-
ing to the Bethesda System in normal, low SIL (LSIL) or
high SIL (HSIL).
Lectin Histochemistry
Paraffin sections (5 μm) were cut and placed on poly-L-
lysine-coated glass slides. The sections were deparaffi-
nized following published methods [24]. Sections were
incubated in methanol containing 0.3% H2O2 for 30 min
to block the activity of endogenous peroxidase. Here-
a f t e r ,e v e r ys t e pw a sf o l l o w e db yw a s h i n gt h r e et i m e s
with 0.1 M Tris-HCl (pH 7.5), 150 mM NaCl. Slides
were incubated with blocking buffer (0.1 M Tris-HCl,
pH 7.5, 0.15 M NaCl, and 0.5% blocking reagent (sup-
plied in kit) for 30 min at room temperature. Sections
were incubated with 5 μg/ml biotin-conjugated lectins
SNA and MAA for 1 h at room temperature. After this,
sections were incubated with horseradish peroxidase-
conjugated streptavidin for 30 min at room temperature.
Biotin signal amplification was performed for 10 min at
room temperature using biotinylated tyramide. Sections
were incubated one more time with horseradish
peroxidase-conjugated streptavidin for 30 min. Colored
reaction product was obtained with 0.01% 3,3-diamino-
benzidine tetrahydrochloride.
To confirm lectin specificity, enzymatic desialylation
was performed by incubating tissue sections with neura-
minidase from C. perfringes (50 mU/ml in 50 mM
citrate pH 6.0, 0.9% NaCl, 0.1% CaCl2)f o r3 0m i na t
37°C. Negative controls of the technique were per-
formed in samples processed without lectin. Sections
were observed in an Olympus microscope (Olympus,
Tokyo, Japan), and the images were processed with the
Metamorph program (Universal Imaging Co., Downing-
town, PA, USA).
The intensity of carbohydrate expression was semi-
quantitatively classified into five groups on the basis of
the intensity of positive cells: 0, negative; 1, 2, 3 and 4
(very low, low, middle and high expression) and was
correlated with histological diagnosis. We also evaluated
the distribution of expression in the different epithelium
layers. The expression was detected in the basal, paraba-
sal, intermediate and superficial layers in order to be
able to differentiate the layers or percentage of the
epithelium when we could not differentiate the layers.
Results
In the present study we analyzed a total of 23 biopsies: 9
cases of LSIL, 9 cases of HSIL and 5 biopsies with nor-
mal epithelium.
Sialic Acid Expression
In order to determine the change in expression of a2,3
and a2,6 linkage sialic acid related to neoplastic trans-
formation of the cervical epithelium, we performed lec-
tin histochemistry assays with MAA and SNA.
a2,3 Sialic Acid Expression
Four out of five normal biopsies showed expression of
a2,3 sialic acid. The higher expression was detected in
the basal layer and only two samples with very low
expression were detected in the medium and superficial
layers (Table 1).
In all samples from the group with LSIL, sialic acid in
a2,3 linkage was detected. They showed low and med-
ium expression in the basal layer. For the intermediate
and superficial layers, the expression was restricted to
three and five samples, respectively with very low or low
expression (Table 1).
Sialic acid expression in a2,3 linkage was detected in
all HSIL samples analyzed (8/8) with a variable intensity
of expression in the basal cells (1-4). The expression
increased in the medium and superficial layers that
extended in most cases to 66% or the total of the
epithelium. In the layers with loss of cellular differentia-
tion, the reaction intensityw a sh i g h e rw i t hr e s p e c tt o
layers with cellular differentiation (Table 1). The general
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increased expression and distribution in the samples
with SIL with respect to normal epithelium (Figure 1).
a2,6 Sialic Acid Expression
a2,6 Sialic acid was detected in all normal samples (5/5).
O n l yo n es a m p l es h o w e de x p r e s s i o ni nt h eb a s a ll a y e r .
All samples showed expression in the medium layers
with variable intensity of expression. Four out of five
samples showed expression in the superficial layers
(Table 2).
I na l lL S I Ls a m p l e s ,a2,6 sialic acid was detected. It
was distributed in the intermediate and superficial
layers. Expression at the basal and intermediate layers
was very low and low, with increased expression in the
superficial layer (Table 2).
All samples with HSIL diagnosis showed a medium
expression of a2,6 sialic acid, with a distribution in all
of them in the intermediate and superficial layer (9/9).
In only two samples, expression in the basal cells was
not detected (Table 2).
The general pattern of a2,6 sialic acid expression
showed an increase in intensity of expression and distri-
bution in HSIL samples. a2,6 Sialic acid expression was
not detected in basal cells, with one exception (Figure 2).
Discussion
Glycoconjugates on the cell surface play important roles
in the regulation of cell proliferation, cell adhesion, can-
cer metastasis, tissue differentiation and apoptosis [7,8].
In particular, sialylation of sugar chains has been sug-
gested to be a very important process during develop-
ment, cancer evolution, and progression, and sialic acid
is often responsible for tumor-associated antigenicity
[25-27]. Several studies in cervical cancer have been
directed to analyze the level of sialic acid in patients’
serum. The results showed that the level of these sugars
is increased in patients with cervical cancer and this
level return to normal after therapy. The level show a
decline in patients who respond well to treatment and
show an increase in patients with recurrence of cancer
Table 1 a2,3 Sialic acid expression and distribution in
samples with normal, LSIL, and HSIL
Normal
# sample Basal Intermediate Superficial
15 3 0 1
16 1 0 0
26 2 1 1
30 0 0 0
34 4 1 0
Mean intensity 2 0.4 0.4
LSIL
11 3 0 0
13 2 0 0
21 2 0 0
22 3 0 0
35 2 2 2
38 3 2 1
41 3 0 1
43 2 1 2
48 3 1 1
Mean intensity 2.6 0.4 0.8
HSIL
17 1 2 2
18 1 2 1
20 2 1 1
23 3 0 0
24 2 1 1
33 2 0 0
39 3 2 2
49 4 1 1
Mean intensity 2.2 1.1 1.0
HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous
intraepithelial lesion. Lectin binding was evaluated as follows: 0, absent; 1,
very low intensity; 2, low intensity; 3, medium intensity and 4, high intensity.
The reaction intensity was evaluated in the different layers of the epithelium
(Basal, Intermediate and Superficial).
Figure 1 a2,3 Sialic acid expression in cervical samples with normal (A), LSIL (B) and HSIL (C) diagnosis.S i a l i ca c i di na2,3 linkage was
recognized with biotinylated MAA lectin. Amplification 100×.
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in sialic acid expression in premalignant lesions has
been scarcely studied. Roy and Chakraborty reported a
slight elevation in benign lesions, moderate elevation in
severe dysplasia and preinvasive carcinoma and higher
elevation in invasive carcinoma of the cervix of this
monosaccharide [13]. The present study describes the
change of a2,3 and a2,6 sialic acid expression in cervi-
cal intraepithelial neoplasia. An increased expression of
sialic acid was detected in both types of linkages related
with the grade of cervical neoplasia in most of the stu-
died samples. a2,3 Sialic acid expression in normal sam-
ples was detected in the basal layer, increasing
distribution to the intermediate layers in LSIL. In some
HSIL it was detected in all layers. a2,6 Sialic acid
expression was not detected in the basal layer but was
detected in the medium and superficial layers and in the
same way that a2 , 3s i a l i ca c i di nH S I Li se x p r e s s e di n
all layers. It is important to note that there exists a co-
expression of both types of sialic acid linkages in the
squamous intraepithelial lesions. The increased sialyla-
tion detected may play an important role in cellular
interactions, changing the structure of the epithelium
and losing definition of the different layers. The change
in sialic acid expression has been correlated in most stu-
dies with a change in the expression of sialyltransferases
genes [7,29,30]. In cervical cancer, an increase in mRNA
levels of sialyltransferases ST3Gal III and ST6Gal I
related with invasion has been detected [22]. A previous
study from our group found an increase in the mRNA
levels of the sialyltransferases ST6Gal I, ST3Gal III and
ST3Gal IV in premalignant lesions of the cervix [23].
The results obtained in the presence study may be as a
result of increased expression of certain sialyltrans-
ferases genes.
Conclusion
Neoplastic transformation in the human cervical epithe-
lium was accompanied by increased expression of a2,6
and a2,3 sialic acids. These results show that the change
in sialylation occurs before cancer development and may
Table 2 a2,6 Sialic acid expression and distribution in
samples with normal, LSIL, and HSIL
Normal
# sample Basal Intermediate Superficial
15 0 3 3
16 0 1 0
26 0 2 1
30 0 1 1
34 3 3 2
Mean intensity 0.6 2.0 1.4
LSIL
11 0 0 3
13 0 2 2
21 0 0 3
22 0 0 1
35 2 2 2
38 1 1 1
41 2 1 3
43 0 1 2
48 1 0 1
Mean intensity 0.7 0.8 2.0
HSIL
13 2 1
17 2 3 3
18 1 4 3
20 1 3 3
23 0 3 3
24 3 3 3
33 3 2 2
39 0 2 3
49 3 1 2
Mean intensity 1.8 2.6 2.6
HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous
intraepithelial lesion. Lectin binding was evaluated as follows: 0, absent; 1,
very low intensity; 2, low intensity; 3, medium intensity and 4, high intensity.
The reaction intensity was evaluated in the different layers of the epithelium
(Basal, Intermediate and Superficial)
Figure 2 a2,6 Sialic acid expression in cervical samples with normal (A), LSIL (B) and HSIL (C) diagnosis.S i a l i ca c i di na2,6 linkage was
recognized with biotinylated SNA lectin. Amplification 100×.
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results may be useful for the development of diagnostic
techniques for cervical intraepithelial neoplasia using
quantitative methods such as flow cytometry.
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